Runaway cell death and inflammation triggered by severe trauma may be interrupted by a drug used to prevent alcohol abuse—and it may be particularly effective in females, according to research led by University of Pittsburgh […]
Researchers from The University of Texas MD Anderson Cancer Center have identified a new biomarker, TTF-1, that was predictive of survival outcomes for patients with advanced KRAS G12C-mutated non-small cell lung cancer (NSCLC), following treatment […]
Researchers at the Max Planck Institute for Biology of Aging have discovered that the combination of the two cancer drugs, rapamycin and trametinib, significantly extends the lifespan of mice. The work has been published in […]
Switching from one selective serotonin reuptake inhibitor (SSRI) to another antidepressant could be used to measure antidepressant non-response, according to new research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London.This […]
A rigorous randomized clinical trial of rizatriptan conducted by UCLA and Mayo Clinic researchers failed to outperform placebo in relieving the acute symptoms of vestibular migraine.This article was originally published on MedicalXpress.com
Every day, nearly 100 children present to Australian emergency departments with suspected medicine poisoning. It’s a startling statistic, but a reality that could be avoided, according to new research from the University of South Australia.This […]
The U.S. Food and Drug Administration has approved Arcutis Biotherapeutics’ Zoryve (roflumilast) topical foam 0.3% for the treatment of plaque psoriasis of the scalp and body in adult and pediatric patients 12 years of age […]
Maintenance therapy with lurbinectedin (lurbi) and atezolizumab (atezo) helps some patients with extensive-stage small cell lung cancer (ES-SCLC) live longer versus maintenance therapy with atezolizumab alone, according to a study presented at the annual meeting […]
A new study from UNC School of Medicine researchers, published this week in Blood, provides fresh insight into how the body forms and dissolves blood clots—and may help reshape how doctors treat patients at risk […]
The U.S. Food and Drug Administration has approved GSK’s Nucala (mepolizumab) as an add-on maintenance treatment for adult patients with inadequately controlled chronic obstructive pulmonary disease (COPD).This article was originally published on MedicalXpress.com
© 2025 SimplyWell.ca